If you take a GLP-1 medicine and have been hospitalised by acute pancreatitis, the Yellow Card Biobank wants to hear from you GLP-1 medicines are licensed for Type 2 diabetes and weight management, and include the branded products Ozempic, Mounjaro and Wegovy The pioneering Yellow Card Biobank, launched by the Medicines and Healthcare products Regulatory Agency (MHRA) and Genomics England, will start investigating whether the risk of acute pancreatitis (inflamed pancreas) from GLP-1 injections for weight loss and Type 2 diabetes may be influenced by an individuals genes
There is no in-person visit
Advanced labs and ongoing monitoring are included for precision and consistency
This could theoretically affect DNA methylation, gene expression, and other processes dependent on methylation
This guide will show you how to use glutathione
Khalili-Tanha G, Radisky ES, Radisky DC, Shoari A